Actively Recruiting
Effect of Continuous Adductor Canal Block Versus Continuous Adductor Canal Block With Additional Infiltration Between The Popliteal Artery and Capsule of The Knee (IPACK) After Arthroscopic Knee Surgeries
Led by Ain Shams University · Updated on 2025-01-31
70
Participants Needed
1
Research Sites
34 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
This study aims to evaluate the effect of Continuous Adductor Canal Block only versus adding posterior knee block, known as the Infiltration between the Popliteal Artery and Capsule of the Knee (IPACK) block with Continuous Adductor Canal Block (CACB) after arthroscopic knee surgeries.
CONDITIONS
Official Title
Effect of Continuous Adductor Canal Block Versus Continuous Adductor Canal Block With Additional Infiltration Between The Popliteal Artery and Capsule of The Knee (IPACK) After Arthroscopic Knee Surgeries
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Age from 21 to 65 years
- Both sexes
- American Society of Anesthesiologists (ASA) Physical Status Class I to II
- Patients with successful spinal anesthesia
- Patients scheduled for elective arthroscopic knee surgery for anterior cruciate ligament (ACL) and posterior cruciate ligament (PCL) repair
You will not qualify if you...
- Declining to give written informed consent
- History of allergy to the medications used in the study
- Contraindications to regional anesthesia including coagulopathy and local infection
- Polytrauma patients having lower limb fractures
- Patients with pre-existing myopathy or neuropathy on the operating limb
- Patients with diabetes mellitus
- Psychiatric disorder
- Morbid obesity (body mass index > 45kg/m2)
- Complicated surgery
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Ain Shams University
Cairo, Egypt, 11591
Actively Recruiting
Research Team
N
Nada E Hussein, Master
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
DOUBLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here